Literature DB >> 31387156

Multiple endocrine neoplasia: an update.

Jane E McDonnell1, Matti L Gild1,2,3, Roderick J Clifton-Bligh1,2,3, Bruce G Robinson1,2,3.   

Abstract

The multiple endocrine neoplasia (MEN) syndromes include MEN1, MEN2 (formerly MEN2A), MEN3 (formerly MEN2B) and the recently identified MEN4. Clinical presentations are varied and often relate to the overproduction of specific hormones. Understanding the genetics of each syndrome assists in determining screening timelines. Treatments for each manifestation are dependent on location, risk of recurrence or malignancy, hormone excess and surgical morbidity. Multidisciplinary management should include geneticists, genetic counsellors, endocrinologists and endocrine surgeons.
© 2019 Royal Australasian College of Physicians.

Entities:  

Keywords:  genetics; multiple endocrine neoplasia; screening

Mesh：

Substances：

Year:  2019        PMID： 31387156     DOI： 10.1111/imj.14394

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


  9 in total

1.  Patients' perception on the quality of care for multiple endocrine neoplasia disorders in Europe: an online survey from a patient support group.

Authors:  Karl Philipp Drewitz; Jo Grey; Petra Brügmann; Josef Pichl; Martina Sammarco; Monique Aarts; Dirk van Genechten; Maria-Luisa Brandi; Ludwig Schaaf
Journal:  Endocrine       Date:  2021-02-03       Impact factor: 3.633

Review 2.  Genetic Basis of ACTH-Secreting Adenomas.

Authors:  Pietro Locantore; Rosa Maria Paragliola; Gianluca Cera; Roberto Novizio; Ettore Maggio; Vittoria Ramunno; Andrea Corsello; Salvatore Maria Corsello
Journal:  Int J Mol Sci       Date:  2022-06-19       Impact factor: 6.208

3.  Multiple endocrine neoplasia type 1 with ectopic parathyroid adenoma.

Authors:  Qiaorui Liu; Liming Wu; Xulei Zheng; Cong Ma; Risu Na; Ling Qiu; Zhiwen Liu; Liyan Liao
Journal:  Arch Med Sci       Date:  2022-04-14       Impact factor: 3.707

4.  Multiple endocrine neoplasia type 1 with refractory hypoglycemia and lung and liver metastases: a case report.

Authors:  Yong Wang; Hui Zhang
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

Review 5.  Nursing Management and Adverse Events in Thyroid Cancer Treatments with Tyrosine Kinase Inhibitors. A Narrative Review.

Authors:  Aurora De Leo; Emanuele Di Simone; Alessandro Spano; Giulia Puliani; Fabrizio Petrone
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

6.  Anesthesia and Outcome of 33 Surgeries in 24 Multiple Endocrine Neoplasia Type 2A (MEN2A) Patients: A National Rare Disease Center's Experience.

Authors:  Yaohan Li; Di Jin; Le Shen; Yuguang Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

7.  Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature.

Authors:  Vanessa Triviño; Olga Fidalgo; Antía Juane; Jorge Pombo; Fernando Cordido
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

8.  Comprehensive Analysis of MEN1 Mutations and Their Role in Cancer.

Authors:  Devi D Nelakurti; Amrit L Pappula; Swetha Rajasekaran; Wayne O Miles; Ruben C Petreaca
Journal:  Cancers (Basel)       Date:  2020-09-14       Impact factor: 6.639

Review 9.  A narrative review of multiple endocrine neoplasia syndromes: genetics, clinical features, imaging findings, and diagnosis.

Authors:  Xuefang Hu; Jian Guan; Yangdi Wang; Siya Shi; Chenyu Song; Zi-Ping Li; Shi-Ting Feng; Jie Chen; Yanji Luo
Journal:  Ann Transl Med       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.